Stephanie B. Hastings, Ph.D. | November 13, 2019

Analytical Validation of Illumina’s TSO500 ctDNA Assay

Presentation given at the Illumina Corporate Workshop at AMP 2019
This presentation provides an overview of Illumina's TruSight Oncology 500 (TSO500) panel and discusses the analytical validation of the TSO500 ctDNA assay (pre-release version).

Download the presentation to learn more.

Related Services:
Non-invasive Detection of Immunotherapy Biomarkers using TruSight Oncology 500 (TSO500)

TSO500 Plasma Assay

Panel-based tumor mutational burden (TMB) analysis of matched tumor and plasma specimens using Illumina’s TruSight Oncology 500 next-generation sequencing assay

AACR 2019 Scientific Poster

Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

Q2 Solutions Genomic Laboratory Services

Genomic Know-How® for your drug development needs

Read More